Comparison of rosuvastatin/ezetimibe tablets versus capsules in healthy volunteers: A single-dose bioequivalence study of 20 mg/10 mg formulations
- Substances:–
Spain- Participants:18–64 years · Healthy volunteers
- Sponsor:Laboratorios Normon S.A.
Rare diseases
Investigational molecules
Locations
Back to Spain3 337 clinical trials in Madrid, Spain across 24 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
SpainStudy of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan
SpainStudy of inhaled interferon beta-1a (SNG001) for treatment of patients with viral lower respiratory tract infections who require mechanical ventilation
SpainStudy of Descartes-08 compared to placebo in adults with generalized myasthenia gravis
SpainStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
SpainStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
SpainLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SpainStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
SpainStudy of Tibulizumab to Treat Adults with Hidradenitis Suppurativa
SpainStudy comparing valemetostat tosylate plus pembrolizumab versus pembrolizumab alone in patients with advanced non-small cell lung cancer with high PD-L1 expression
SpainStudy of zorevunersen to reduce seizures in patients with Dravet syndrome
SpainLong-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial
SpainThe busiest research cities in the country
What the registry says about research in the country
Investigating novel treatments for cutaneous lupus erythematosus and immune thrombocytopenia, with studies evaluating new therapeutic approaches to manage these challenging conditions.
Research focuses on improving treatment outcomes and quality of life for patients with autoimmune disorders.
Clinical trials examining innovative therapies for Type 1 Diabetes in combination with weight management, targeting both glycemic control and obesity-related complications.
Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.
Breakthrough research in multiple sclerosis and acute ischemic stroke, exploring new therapeutic options for both pediatric and adult populations.
Focus on developing targeted treatments to improve neurological outcomes and patient care.
Comprehensive vaccine studies targeting respiratory syncytial virus, influenza, and herpes zoster, with particular attention to vulnerable populations.
Research aims to enhance protection against common and serious infectious diseases.
Innovative studies in mantle cell lymphoma and bladder cancer, exploring combination therapies and targeted treatments to improve patient outcomes.
Focus on developing more effective and personalized cancer treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.